Alex Janin

It’s still up to the FDA to decide whether to greenlight the substances for compounding pharmacies to make—and pave the way for a peptide gold rush

Biohackers, longevity enthusiasts and alternative medicine doctors want the peptide BPC-157. Now compounders may be one step closer to lawfully providing it.

Samples—and a certain stink—are accumulating at Quest Diagnostics thanks to the cyclosporiasis outbreak. “You get used to it.”

Eli Lilly’s shares rose 7% after the drugmaker reported a 48% year-over-year jump in quarterly revenue that beat analyst estimates. Mounjaro and Zepbound drove the result, which Citi analysts said is proof the diabetes and weight-loss markets are still growing. The drugmaker increased its full-year

CLIFTON, N.J.—On a laboratory table that normally sits empty, hundreds of feces samples are arranged in stacks six vials high.

If patients turning to the Internet for medical advice wasn't enough, doctors now have a new, more powerful version of “Dr. Google” to contend with.

Roughly a third of adults now consult AI for health advice, leaving doctors to untangle erroneous guidance.

Hacks have raised safety alarms, but researchers say their experiment could protect against drug-resistant bacteria and save lives.

While hacks have raised safety alarms, researchers said their experiment could protect against drug-resistant bacteria and save lives.

Biohackers, longevity enthusiasts and alternative medicine doctors want the peptide BPC-157. Now compounders may be one step closer to lawfully providing it.